Methacrylic Acid

Methacrylic Acid

SCHEMBL890416

C=C(C)C(=O)O.C=C(C)C(=O)OCC(O)CO.O=P(O)(O)O

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Methacrylic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.49
KDM4E B2RXH2 1/20 0.37
DUSP3 P51452 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
LMNA P02545 1/20 0.37
ALDH1A1 P00352 2/20 0.37
THRB P10828 1/20 0.35
DGKA P23743 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
FAAH O00519 2/20 0.31
TGFBR1 P36897 1/20 0.31
LPAR6 P43657 1/20 0.31
LPAR1 Q92633 1/20 0.31
LPAR4 Q99677 1/20 0.31
LPAR5 Q9H1C0 1/20 0.31
LPAR2 Q9HBW0 1/20 0.31
LPAR3 Q9UBY5 1/20 0.31
ENPP2 Q13822 1/20 0.31
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL16620209 0.95 TSHR (0.53) TSHRKDM4EDUSP3MEN1KMT2A
Phosphoric Acid SCHEMBL4988141 0.95 TSHR (0.53) TSHRKDM4EDUSP3MEN1KMT2A
Methacrylic Acid SCHEMBL8075678 0.94 TSHR (0.46) TSHRKDM4EDUSP3MEN1KMT2A
Methacrylic Acid SCHEMBL25415594 0.93 TSHR (0.55) TSHRKDM4EDUSP3MEN1KMT2A
Methacrylic Acid SCHEMBL33306 0.93 TSHR (0.55) TSHRKDM4EDUSP3MEN1KMT2A
Methacrylic Acid SCHEMBL5435140 0.93 TSHR (0.55) TSHRKDM4EDUSP3MEN1KMT2A
Methacrylic Acid SCHEMBL283894 0.93 TSHR (0.55) TSHRKDM4EDUSP3MEN1KMT2A
Bicarbonate SCHEMBL28904630 0.88 TSHR (0.57) TSHRKDM4EDUSP3MEN1KMT2A
SCHEMBL16863053 0.88 TSHR (0.61) TSHRKDM4EDUSP3MEN1KMT2A
SCHEMBL25707 0.88 TSHR (0.61) TSHRKDM4EDUSP3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109401560-B High-turnover-frequency ultraviolet-cured aluminum template release agent and preparation method thereof 湖南汇田高分子科技有限公司 2021-10-08 CN claimed
EP-0973482-B2 DENTAL PRIMER COMPOSITIONS MINNESOTA MINING & MFG (US) 2020-03-18 EP claimed
US-8664294-B2 Self etch all purpose dental cement composition and method of use thereof PENTRON CLINICAL TECHNOLOGIES, LLC (US) 2014-03-04 US claimed
US-20110171608-A1 SELF ETCH ALL PURPOSE DENTAL CEMENT COMPOSITION AND METHOD OF USE THEREOF PENTRON CLINICAL TECHNOLOGIES, L.L.C. (US) 2011-07-14 US claimed
EP-0973482-B1 DENTAL PRIMER COMPOSITIONS MINNESOTA MINING & MFG (US) 2005-01-19 EP claimed
US-6482871-B1 Method for adhering to hard tissue 3M INNOVATIVE PROPERTIES COMPANY 2002-11-19 US claimed
EP-0973482-A1 DENTAL PRIMER COMPOSITIONS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 2000-01-26 EP claimed
US-5922786-A PART A COMPRISES AN ACIDIC POLYMERIZABLE COMPOUND AND POLYMERIZABLE DILUENT SELECTED SO THAT IF WATER IS PRESENT, THE PH OF PART A IS GREATER THAN 2; PART B COMPRISES AN ACIDIC MATERIAL SUCH THAT THE PH IS 2; NO ETCHING STEP NEEDED MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1999-07-13 US claimed
WO-1998046198-A1 DENTAL PRIMER COMPOSITIONS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1998-10-22 WO claimed
CN-109401560-B High-turnover-frequency ultraviolet-cured aluminum template release agent and preparation method thereof 湖南汇田高分子科技有限公司 2021-10-08 CN disclosed
EP-0973482-B2 DENTAL PRIMER COMPOSITIONS MINNESOTA MINING & MFG (US) 2020-03-18 EP disclosed
US-9901519-B2 Infiltrant for dental ceramics MUHLBAUER TECHNOLOGY GMBH (DE) 2018-02-27 US disclosed
US-9833387-B2 Kit and method for indirect chairside production of composite inlays VOCO GMBH (DE) 2017-12-05 US disclosed
US-9610235-B2 Methods and compositions to improve mechanical resistance of teeth THEOCORP HOLDING CO., LLC (US) 2017-04-04 US disclosed
WO-1993012760-A1 METHOD FOR ADHERING TO HARD TISSUE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1993-07-08 WO disclosed
US-4966934-A DIPENTAERYTHRITOL PENTAACRYLATE PHOSPHATE ESTER; DENTISTRY DENTSPLY RESEARCH & DEVELOPMENT CORP. (US) 1990-10-30 US disclosed
EP-0363903-A2 Adhesive containing pit and fissure sealants DENTSPLY INTERNATIONAL (US) 1990-04-18 EP disclosed
US-4816495-A UNSATURATED PHOSPHATES AS ADHESION PROMOTERS DENTSPLY RESEARCH & DEVELOPMENT CORP. (US) 1989-03-28 US disclosed
US-4657941-A USED IN DENTISTRY DENTSPLY RESEARCH & DEVELOPMENT CORP. (US) 1987-04-14 US disclosed
EP-0183027-A2 Biologically compatible adhesive DENTSPLY INTERNATIONAL, INC. (US) 1986-06-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110171608-A1 SELF ETCH ALL PURPOSE DENTAL CEMENT COMPOSITION AND METHOD OF USE THEREOF FHIT, ASPH, ACR TSHR 4798/4885KDM4E 1761/4885DUSP3 2450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.